Sowell Financial Services LLC Reduces Stake in Phibro Animal Health Corporation $PAHC

Sowell Financial Services LLC cut its position in shares of Phibro Animal Health Corporation (NASDAQ:PAHC) by 37.7% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 59,322 shares of the company’s stock after selling 35,920 shares during the quarter. Sowell Financial Services LLC’s holdings in Phibro Animal Health were worth $2,400,000 as of its most recent filing with the SEC.

Several other large investors also recently bought and sold shares of the company. Trexquant Investment LP acquired a new position in shares of Phibro Animal Health during the 1st quarter worth $385,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Phibro Animal Health by 4.7% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 12,164 shares of the company’s stock valued at $260,000 after acquiring an additional 546 shares in the last quarter. Millennium Management LLC increased its holdings in Phibro Animal Health by 74.3% during the 1st quarter. Millennium Management LLC now owns 362,030 shares of the company’s stock valued at $7,733,000 after acquiring an additional 154,281 shares in the last quarter. Jane Street Group LLC raised its position in Phibro Animal Health by 65.3% during the first quarter. Jane Street Group LLC now owns 33,917 shares of the company’s stock worth $724,000 after acquiring an additional 13,404 shares during the last quarter. Finally, Acadian Asset Management LLC lifted its holdings in shares of Phibro Animal Health by 0.5% in the first quarter. Acadian Asset Management LLC now owns 782,939 shares of the company’s stock valued at $16,713,000 after purchasing an additional 4,144 shares in the last quarter. Institutional investors and hedge funds own 99.34% of the company’s stock.

Phibro Animal Health Trading Up 1.1%

Shares of PAHC opened at $38.17 on Monday. Phibro Animal Health Corporation has a fifty-two week low of $16.16 and a fifty-two week high of $46.42. The company has a market capitalization of $1.55 billion, a PE ratio of 22.99, a price-to-earnings-growth ratio of 1.08 and a beta of 0.77. The stock has a fifty day moving average of $41.44 and a two-hundred day moving average of $35.68. The company has a debt-to-equity ratio of 2.32, a quick ratio of 1.35 and a current ratio of 3.09.

Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings data on Wednesday, November 5th. The company reported $0.73 EPS for the quarter, beating analysts’ consensus estimates of $0.58 by $0.15. The business had revenue of $363.89 million during the quarter, compared to the consensus estimate of $345.44 million. Phibro Animal Health had a return on equity of 36.26% and a net margin of 4.85%.Phibro Animal Health has set its FY 2026 guidance at 2.640-2.810 EPS. As a group, analysts forecast that Phibro Animal Health Corporation will post 1.95 EPS for the current year.

Phibro Animal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, December 17th. Stockholders of record on Wednesday, November 26th were paid a dividend of $0.12 per share. The ex-dividend date of this dividend was Wednesday, November 26th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.3%. Phibro Animal Health’s dividend payout ratio is currently 28.92%.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on PAHC. Zacks Research raised shares of Phibro Animal Health from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, December 9th. JPMorgan Chase & Co. boosted their price target on Phibro Animal Health from $45.00 to $50.00 and gave the stock an “overweight” rating in a report on Friday, November 7th. Finally, Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Phibro Animal Health in a research note on Monday, December 22nd. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, three have assigned a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $31.40.

Insider Buying and Selling at Phibro Animal Health

In other news, CEO Jack Bendheim sold 38,303 shares of the stock in a transaction dated Monday, November 10th. The shares were sold at an average price of $45.29, for a total transaction of $1,734,742.87. Following the transaction, the chief executive officer directly owned 20,577 shares in the company, valued at $931,932.33. This represents a 65.05% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. In the last 90 days, insiders have sold 146,554 shares of company stock worth $6,338,444. Corporate insiders own 50.13% of the company’s stock.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation (NASDAQ: PAHC) is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro’s portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.

The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.